53 related articles for article (PubMed ID: 35220072)
21. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.
Munkhdelger J; Choi Y; Lee D; Kim S; Kim G; Park S; Choi E; Jin H; Jeon BY; Lee H; Park KH
Diagn Microbiol Infect Dis; 2014 Aug; 79(4):422-7. PubMed ID: 24856365
[TBL] [Abstract][Full Text] [Related]
22. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions.
Coutlée F; Trottier H; Gagnon S; Koushik A; Richardson H; Roger M; Ferenczy AS; Franco EL
J Clin Virol; 2009 Jun; 45(2):96-9. PubMed ID: 19398216
[TBL] [Abstract][Full Text] [Related]
23. Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions.
Yoshida T; Sano T; Kanuma T; Owada N; Sakurai S; Fukuda T; Nakajima T
Int J Gynecol Cancer; 2008; 18(1):121-7. PubMed ID: 17506843
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
Obiri-Yeboah D; Akakpo PK; Mutocheluh M; Adjei-Danso E; Allornuvor G; Amoako-Sakyi D; Adu-Sarkodie Y; Mayaud P
BMC Cancer; 2017 Oct; 17(1):688. PubMed ID: 29037188
[TBL] [Abstract][Full Text] [Related]
25. STAT1 expression and HPV16 viral load predict cervical lesion progression.
Wu S; Wu Y; Lu Y; Yue Y; Cui C; Yu M; Wang S; Liu M; Zhao Y; Sun Z
Oncol Lett; 2020 Oct; 20(4):28. PubMed ID: 32774501
[TBL] [Abstract][Full Text] [Related]
26. [Expression purification and clinical application of high-risk HPV16 E4 gene].
Gao YE; Hui H; Zhang J; Fan JB; Yan XJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):676-81. PubMed ID: 18772505
[TBL] [Abstract][Full Text] [Related]
27. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.
Sasagawa T; Basha W; Yamazaki H; Inoue M
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):45-52. PubMed ID: 11205488
[TBL] [Abstract][Full Text] [Related]
28. Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer.
Shukla S; Mahata S; Shishodia G; Pande S; Verma G; Hedau S; Bhambhani S; Kumari A; Batra S; Basir SF; Das BC; Bharti AC
Indian J Med Res; 2014 Apr; 139(4):531-43. PubMed ID: 24927339
[TBL] [Abstract][Full Text] [Related]
29. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
Ding Z; Li Y; Chen A; Song M; Zhang Y
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
[TBL] [Abstract][Full Text] [Related]
30. Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns.
Schmitt M; Dalstein V; Waterboer T; Clavel C; Gissmann L; Pawlita M
Cancer Res; 2010 Jan; 70(1):249-56. PubMed ID: 20028865
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus genotypes associated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China.
Zhao J; Guo Z; Wang Q; Si T; Pei S; Wang C; Qu H; Zhong J; Ma Y; Nie C; Zhang D
Infect Agent Cancer; 2017; 12():8. PubMed ID: 28138337
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppression in cervical cancer with special reference to arginase activity.
Bedoya AM; Tate DJ; Baena A; Córdoba CM; Borrero M; Pareja R; Rojas F; Patterson JR; Herrero R; Zea AH; Sanchez GI
Gynecol Oncol; 2014 Oct; 135(1):74-80. PubMed ID: 25084511
[TBL] [Abstract][Full Text] [Related]
33. Single Nucleotide Polymorphisms in the Arginase 1 and 2 Genes Are Differentially Associated with Circulating l-Arginine Concentration in Unsupplemented and l-Arginine-Supplemented Adults.
Hannemann J; Rendant-Gantzberg L; Zummack J; Hillig J; Eilermann I; Böger R
J Nutr; 2021 Apr; 151(4):763-771. PubMed ID: 33232463
[TBL] [Abstract][Full Text] [Related]
34. OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer.
Grzybowski MM; Stańczak PS; Pomper P; Błaszczyk R; Borek B; Gzik A; Nowicka J; Jędrzejczak K; Brzezińska J; Rejczak T; Güner-Chalimoniuk NC; Kikulska A; Mlącki M; Pęczkowicz-Szyszka J; Olczak J; Gołębiowski A; Dzwonek K; Dobrzański P; Zasłona Z
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010962
[TBL] [Abstract][Full Text] [Related]
35. Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2.
Detroja TS; Samson AO
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014374
[TBL] [Abstract][Full Text] [Related]
36. Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy.
Borek B; Nowicka J; Gzik A; Dziegielewski M; Jedrzejczak K; Brzezinska J; Grzybowski M; Stanczak P; Pomper P; Zagozdzon A; Rejczak T; Matyszewski K; Golebiowski A; Olczak J; Lisiecki K; Tyszkiewicz M; Kania M; Piasecka S; Cabaj A; Dera P; Mulewski K; Chrzanowski J; Kusmirek D; Sobolewska E; Magdycz M; Mucha L; Masnyk M; Golab J; Nowotny M; Nowak E; Napiorkowska-Gromadzka A; Pikul S; Jazwiec R; Dzwonek K; Dobrzanski P; Meyring M; Skowronek K; Iwanowski P; Zaslona Z; Blaszczyk R
Mol Cancer Ther; 2023 Jul; 22(7):807-817. PubMed ID: 36939275
[TBL] [Abstract][Full Text] [Related]
37. Determination of Serum Arginase-1 Concentrations and Serum Arginase Activity for the Non-Invasive Diagnosis of Endometriosis.
Pliszkiewicz M; Czystowska-Kuzmicz M; Soroczynska K; Siekierski BP; Safranow K
J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592313
[No Abstract] [Full Text] [Related]
38. Arginase-1 promotes lens epithelial-to-mesenchymal transition in different models of anterior subcapsular cataract.
Li Q; Wang Y; Shi L; Wang Q; Yang G; Deng L; Tian Y; Hua X; Yuan X
Cell Commun Signal; 2023 Sep; 21(1):236. PubMed ID: 37723490
[TBL] [Abstract][Full Text] [Related]
39. TIME Is Ticking for Cervical Cancer.
Kumar V; Bauer C; Stewart JH
Biology (Basel); 2023 Jun; 12(7):. PubMed ID: 37508372
[TBL] [Abstract][Full Text] [Related]
40. Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression.
Giannoudis A; Varešlija D; Sharma V; Zakaria R; Platt-Higgins A; Rudland PS; Jenkinson MD; Young LS; Palmieri C
ESMO Open; 2022 Dec; 7(6):100636. PubMed ID: 36423363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
